Home/Filings/4/0001209191-22-060691
4//SEC Filing

Amello Jason 4

Accession 0001209191-22-060691

CIK 0001841387other

Filed

Dec 11, 7:00 PM ET

Accepted

Dec 12, 4:25 PM ET

Size

7.1 KB

Accession

0001209191-22-060691

Insider Transaction Report

Form 4
Period: 2022-12-08
Amello Jason
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2022-12-08$1.69/sh+3,100$5,2393,100 total
  • Purchase

    Common Stock

    2022-12-09$1.93/sh+2,468$4,7635,568 total
Footnotes (2)
  • [F1]The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.55 to $1.78. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.85 to $2.00. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Issuer

Candel Therapeutics, Inc.

CIK 0001841387

Entity typeother

Related Parties

1
  • filerCIK 0001451805

Filing Metadata

Form type
4
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 4:25 PM ET
Size
7.1 KB